The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates
- PMID: 1917516
- DOI: 10.1016/0883-2897(91)90107-v
The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates
Abstract
Yttrium binding ligands DOTA, caDTPA and CT-DTPA were each conjugated to monoclonal antibody B72.3, labelled with 90Y and injected into mice in order to assess the in vivo inertness of the antibody-linked 90Y-ligand complexes. Levels of 90Y in femur shafts of the DOTA-B72.3 mice were low, being approximately 7 and 44%, respectively, of levels in the femur shafts of the caDTPA-B72.3 and CT-DTPA-B72.3 treated mice. This finding demonstrates the greater inertness and by implication the greater suitability for immunotherapy of the DOTA-90Y complex.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources